CPT code 0262U: Tumor pathway profile, seven pathway activity score2026 Medicare lab fee · Clinical Laboratory Fee Schedule
This molecular assay profiles mRNA expression across seven pathways in solid tumor tissue and reports an algorithm-derived pathway activity score.
Medicare pays $3,200.00 for 0262U under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$3,200.00
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2023
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 8 sections
What 0262U covers
0262U describes mRNA gene expression profiling across seven pathways in solid organ tumor tissue. The assay uses real-time RT-PCR on formalin-fixed, paraffin-embedded tissue and reports an algorithm-derived pathway activity score. The pathways assessed are estrogen receptor, androgen receptor, PI3K, MAPK, Hedgehog, TGF-beta, and Notch.
Report 0262U for the seven-pathway assay as a whole; the pathways are not separate code lines. Medicare pays the test through the Clinical Laboratory Fee Schedule (CLFS), at one national amount across localities, without geographic or office-versus-facility adjustment. The 2026 national CLFS amount is $3,200.00, unchanged from 2023 through 2026. Medicare payment for this code is through the CLFS rather than a separate physician fee schedule payment.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 0262U
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 0262U. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Not on the physician fee schedule
The physician fee schedule doesn’t list 0262U: Medicare pays the test only from the CLFS.
0262U on the lab fee schedule since 2021
0262U · CLFS 2026 Q4 (current)
$3,200.00
Unchanged since Jan 1, 2023
Every change on file
- Jan 1, 2023 · CLFS 2023 Q1MAC-priced → $3,200.00
21 quarterly CLFS releases on file, first CLFS 2021 Q4. A code missing from a quarter wasn’t on that release.
0262U compared with similar tests
- 81445Tumor gene panel5–50 genes, DNA or DNA/RNA$597.91
- 81445 describes a solid tumor sequencing panel of 5–50 genes. 0262U profiles mRNA expression across seven pathways and reports a pathway activity score.
- 81455Tumor genomic panel51+ genes, DNA or DNA/RNA$2,919.60
- 81455 describes a solid tumor sequencing panel of 51 or more genes. 0262U is an mRNA pathway-expression assay, not a gene-count sequencing panel.
0262U billing questions
What does 0262U measure?
It profiles mRNA expression across seven pathways in solid organ tumor tissue and reports an algorithm-derived pathway activity score.
What specimen is analyzed?
The assay uses formalin-fixed, paraffin-embedded solid organ tumor tissue.
Are the seven pathways billed separately?
No. They are components of the single seven-pathway assay reported with 0262U.
How does 0262U differ from solid tumor sequencing panels?
0262U reports pathway activity from mRNA expression. Codes 81445 and 81455 describe solid tumor sequencing panels, distinguished by the number of genes analyzed.
How does Medicare pay for 0262U?
Medicare pays 0262U through the CLFS at one national amount across localities, with no office-versus-facility adjustment.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 0262U and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist